Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas

International Journal of Oncology

Volumn 33, Issue 1, 2008, Pages 69-79

  Li, Xiaohan ^a,b   Zheng, Huachuan ^a   Hara, Takuo ^c   Takahashi, Hiroyuki ^b   Masuda, Shinji ^c   Wang, Zhigang ^a   Yang, XiangHong ^a   Guan, Yifu ^a   Takano, Yasuo ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TOYAMA   (Japan)

^c Kouseiren Takaoka Hospital   (Japan)

Author keywords

Cortactin; Fascin; Gastric carcinoma; Pathogenesis; Prognosis; Progression

Indexed keywords

CORTACTIN; FASCIN; TUMOR MARKER; ACTIN BINDING PROTEIN; CARRIER PROTEIN; CTTN PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA; SURVIVAL RATE; TUMOR VOLUME; UNIVARIATE ANALYSIS; CHEMISTRY; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CELL LINE, TUMOR; CORTACTIN; FEMALE; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 51049117743     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.33.1.69     Document Type: Article

References (31)

1. Gupta GP and Massague J: Cancer metastasis: building a framework. Cell 127: 679-695, 2006.
2. Buday L and Downward J: Roles of cortactin in tumor pathogenesis. Biochim Biophys Acta 1775: 263-273, 2007.
3. Hashimoto Y, Ito T, Inoue H, Okumura T, Tanaka E, Tsunoda S, Higashiyama M, Watanabe G, Imamura M and Shimada Y: Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin Cancer Res 11: 2597-2605, 2005.
4. Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, Raben D and Weed SA: Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66: 8017-8025, 2006.
5. Chuma M, Sakamoto M, Yasuda J, Fujii G, Nakanishi K, Tsuchiya A, Ohta T, Asaka M and Hirohashi S: Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma. J Hepatol 41: 629-636, 2004.
6. Greer RO Jr, Said S, Shroyer KR, Marileila VG and Weed SA: Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma. Oral Oncol 43: 735-741, 2007.
7. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y, Zhang X, Sun YT, Zhan QM, Wu M and Wang MR: Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 66: 11690-11699, 2006.
8. Hashimoto Y, Skacel M and Adams JC: Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int J Biochem Cell Biol 37: 1787-1804, 2005.
9. Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G and Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer 6: 241, 2006.
10. Tao YS, Edwards RA, Tubb B, Wang S, Bryan J and McCrea PD: Beta-catenin associates with the actin-bundling protein fascin in a noncadherin complex. J Cell Biol 134: 1271-1281, 1996.
11. Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A and Robine S: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853, 2007.
12. Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M and Adams JC: Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro. Am J Pathol 162: 69-80, 2003.
13. Yamaguchi H, Inoue T, Eguchi T, Miyasaka Y, Ohuchida K, Mizurnoto K, Yamada T, Yamaguchi K, Tanaka M and Tsuneyoshi M: Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade. Mod Pathol 20: 552-561, 2007.
14. Choi PJ, Yang DK, Son CH, Lee KE, Lee JI and Roh MS: Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Eur J Cardiothorac Surg 30: 538-542, 2006.
15. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays. J Cancer Res Clin Oncol 132: 817-823, 2006.
16. Kelley JR and Duggan JM: Gastric cancer epidemiology and risk factors. J Clin Epidemiol 56: 1-9, 2003.
17. Sobin LH and Wittekind CH (eds): TNM Classification of Malignant Tumours. 6th edition, John Wiley & Sons, Hoboken, New Jersey, 2002.
18. Zheng H, Takahashi H, Nakajima T, Murai Y, Cui Z, Nomoto K, Tsuneyama K and Takano Y: Pathobiological characteristics of intestinal- and diffuse-type gastric carcinoma in Japan: an inummostaining study on the tissue microarray. J Clin Pathol 60: 273-277, 2007.
19. Kumada. T, Tsuneyama K, Hatta H, Ishizawa S and Takano Y: Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol 17: 1141-1149, 2004.
20. Clark ES, Whigham AS, Yarbrough WG and Weaver AM: Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67: 4227-4235, 2007.
21. Hill A, McFarlane S, Mulligan K, Gillespie H, Draffin JE, Trimble A, Ouhtit A, Johnston PG, Harkin DP, McCormick D and Waugh DJ: Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 25: 6079-6091, 2006.
22. van Rossum AG, Gibcus J, van der Wal J and Schuuring E: Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells. Breast Cancer Res 7: 235-237, 2005.
23. Head JA, Jiang D, Li M, Zorn LJ, Schaefer EM, Parsons JT and Weed SA: Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell 14: 3216-3229, 2003.
24. Lee TK, Poon RT, Man K, Guan XY, Ma S, Liu XB, Myers JN and Yuen AP: Fascin over-expression is associated with aggressiveness of oral squamous cell carcinoma. Cancer Lett 254: 308-315, 2007.
25. Tsai WC, Chao YC, Sheu LF, Chang JL, Nieh S and Jin JS: Overexpression of fascin-1 in advanced colorectal adeno-carcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters. Dis Markers 23: 153-160, 2007.
26. Jin JS, Yu CP, Sun GH, Lin YF, Chiang H, Chao TK, Tsai WC and Sheu LF: Increasing expression of fascin in renal cell carcinoma associated with clinicopathological parameters of aggressiveness. Histol Histopathol 21: 1287-1293, 2006.
27. Zheng H, Tsuneyama K, Cheng C, Takahashi H, Cui Z, Murai Y, Nomoto K and Takano Y: An immunohistochemical study of P53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res 26: 2353-2360, 2006.
28. Hashimoto Y, Shimada Y, Kawamura J, Yamasaki S and Imamura M: The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67: 262-270, 2004.
29. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J and Lowy AM: Beta-catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62: 3503-3506, 2002.
30. Kimura M, Tsuda H, Morita D, Ichikura T, Ogata S, Aida S, Yoshizumi Y, Maehara T, Mochizuki H and Matsubara O: A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch 445: 255-262,2004.
31. Grothey A, Hashizume R, Ji H, Tubb BE, Patrick CW Jr, Yu D, Mooney EE and McCrea PD: C-erbB-2/HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines. Oncogene 19: 4864-4875, 2000.